Education
About Us
Working with TipRanks
Follow Us
ProstaLund AB (SE:PLUN)
:PLUN
PLUN Stock Chart & Stats
Day’s Range― - ―
52-Week Rangekr4.84 - kr46.13
Previous CloseN/A
Volume452.00
Average Volume (3M)2.88K
Market Cap
kr25.91M
Enterprise Valuekr12.27M
Total Cash (Recent Filing)kr7.82M
Total Debt (Recent Filing)kr933.00K
Price to Earnings (P/E)―
Beta-0.04
Next Earnings
May 30, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-10.04
Shares Outstanding3,624,052
10 Day Avg. Volume1,106
30 Day Avg. Volume2,879
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
PLUN FAQ
What was ProstaLund AB’s price range in the past 12 months?
ProstaLund AB lowest stock price was kr4.84 and its highest was kr46.13 in the past 12 months.
What is ProstaLund AB’s market cap?
ProstaLund AB’s market cap is kr25.91M.
When is ProstaLund AB’s upcoming earnings report date?
ProstaLund AB’s upcoming earnings report date is May 30, 2025 which is in 34 days.
How were ProstaLund AB’s earnings last quarter?
ProstaLund AB released its earnings results on Feb 20, 2025. The company reported -kr2.43 earnings per share for the quarter, missing the consensus estimate of N/A by -kr2.43.
Is ProstaLund AB overvalued?
According to Wall Street analysts ProstaLund AB’s price is currently Overvalued.
Does ProstaLund AB pay dividends?
ProstaLund AB does not currently pay dividends.
What is ProstaLund AB’s EPS estimate?
ProstaLund AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ProstaLund AB have?
ProstaLund AB has 3,624,052 shares outstanding.
What happened to ProstaLund AB’s price movement after its last earnings report?
ProstaLund AB reported an EPS of -kr2.43 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -19.663%.
Which hedge fund is a major shareholder of ProstaLund AB?
Currently, no hedge funds are holding shares in SE:PLUN
---
Company Description
ProstaLund AB
ProstaLund AB is a Swedish medical technology company operating in the healthcare sector. The company specializes in developing and commercializing innovative products and solutions for minimally invasive treatment of benign prostatic hyperplasia (BPH). Its flagship product, the CoreTherm system, utilizes a proprietary technology for thermal treatment of BPH, offering patients an effective alternative to surgical procedures.
---
Technical Analysis
Active Biotech AB
―
Scandinavian ChemoTech AB Class B
―
LIDDS AB
―
Prostatype Genomics AB
―
---